Issue 11, 2017
From the journal:

MedChemComm

Correction: Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity

D. Maciejewska,*a   J. Żabiński,a   M. Rezler,a   P. Kaźmierczak,a   M. S. Collins,bc   L. Fickerbc  and  M. T. Cushion*bc  

* Corresponding authors

a Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland
E-mail: dmaciejewska@wum.edu.pl

b Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
E-mail: cushionmt@ucmail.uc.edu

c Cincinnati Veterans Affairs Medical Center, 3200 Vine Street, Cincinnati, OH 45220, USA

Abstract

Correction for ‘Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity’ by D. Maciejewska et al., Med. Chem. Commun., 2017, 8, 2003–2011.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C7MD90042B
Article type
Correction
Submitted
30 Oct 2017
Accepted
30 Oct 2017
First published
07 Nov 2017
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2017,8, 2164-2164

Permissions

Request permissions

Correction: Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity

D. Maciejewska, J. Żabiński, M. Rezler, P. Kaźmierczak, M. S. Collins, L. Ficker and M. T. Cushion, Med. Chem. Commun., 2017, 8, 2164 DOI: 10.1039/C7MD90042B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements